iotaMotion

iotaMotion

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $14.5M

Overview

Founded in 2016 and based in Iowa City, iotaMotion is a private, pre-revenue medical device company focused on revolutionizing cochlear implant surgery. Its core technology is an automated, surgeon-guided insertion system designed to replace manual techniques, with the goal of reducing variability, minimizing trauma, and improving the functional placement of the electrode array. The company targets a clear need within the established and growing global cochlear implant market by addressing a key procedural bottleneck. Success hinges on clinical validation, regulatory clearance, and adoption by otologic surgeons.

OtologyHearing Loss

Technology Platform

Automated, surgeon-controlled insertion system for cochlear implant electrode arrays designed to standardize the surgical procedure, reduce insertion trauma, and improve hearing preservation outcomes.

Funding History

2
Total raised:$14.5M
Series A$12M
Seed$2.5M

Opportunities

The global cochlear implant market is large and growing, with a clear need for standardized surgical tools.
Successful demonstration of hearing preservation could make the technology a new standard of care.
The platform may also be adapted for intracochlear drug delivery, expanding its applications.

Risk Factors

Clinical trials must conclusively prove superior outcomes over manual insertion to drive adoption.
The company faces regulatory hurdles and the challenge of changing established surgical practices.
Competition from large implant manufacturers developing in-house solutions is a significant threat.

Competitive Landscape

The cochlear implant market is dominated by three large device makers (Cochlear, Advanced Bionics, MED-EL). iotaMotion operates as an enabling technology partner rather than a direct competitor. However, these incumbents or other startups could develop similar assisted-insertion systems, creating competition for this niche surgical tool segment.